Handelsavisen
prelaunch
Companies Basic Materials GIVN.S
GI
GIVN.S Specialty Chemicals

Givaudan SA

$3 263,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
2,59 %
Op margin
ROE
Net margin
Debt / equity
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Givaudan SA is a global leader in the development, production, and marketing of fragrances and flavorings, serving the consumer goods and food industries.

Business. Givaudan SA (GIVN.S) is a specialty chemicals company headquartered in Switzerland. The firm operates within the Basic Materials sector, specifically focusing on the Chemicals industry group. It is primarily listed under the ticker GIVN.S. Specific details regarding operating segments and geographic revenue mix are not provided.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustrySpecialty Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
HOLD23 analysts
9 buy11 hold3 sell
Avg 12m price target3 360,87

Analyst recommendations

23 analysts · consensus Hold
Buy9
Hold11
Sell3
12-month price target
3 360,87
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
23 analysts · indicative
Ownership
PNC Investments LLC
largest disclosed fund holder
Profitability
not yet wired
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning GIVN.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to GIVN.S. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Givaudan SA (GIVN.S) is a specialty chemicals company headquartered in Switzerland. The firm operates within the Basic Materials sector, specifically focusing on the Chemicals industry group. It is primarily listed under the ticker GIVN.S. Specific details regarding operating segments and geographic revenue mix are not provided.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustrySpecialty Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Givaudan maintains a fully diluted share count of 9,229,197 shares, with no dilution observed between basic and diluted shares, indicating no current dilutive instruments outstanding. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.

    Profitability metrics are not available in the valuation snapshot, and no industry_config preferred metrics are provided for comparison. This limits the ability to assess Givaudan’s returns relative to its peers in the Specialty Chemicals industry.

    Givaudan’s revenue is concentrated in its two core segments: Fragrances and Flavors. The company operates globally, with significant exposure to North America and Europe, though specific geographic revenue breakdowns are not disclosed in the available data.

    Outlook data is not provided in the input, and historical revenue growth rates are absent, making it difficult to assess the company’s growth trajectory. Analysts have issued a mean price target of 3,360.87 CHF, with a median of 3,250.00 CHF, suggesting a generally positive sentiment.

    Risk assessment indicates low dilution risk, but liquidity risk remains unassessed due to missing balance-sheet data. No dilution sources are explicitly cited in the input, and no adjustments are noted in the custom valuations.

    Recent events include analyst estimates and price targets, with 4 strong-buy, 5 buy, and 11 hold recommendations. No recent filings or transcripts are provided in the input to inform operational or strategic developments.

    Key takeaways
    • Givaudan has no current dilutive instruments outstanding, as basic and diluted shares are equal.
    • Analysts have a generally positive outlook, with a mean price target of 3,360.87 CHF.
    • Liquidity risk could not be assessed due to missing balance-sheet data.
    • Revenue is concentrated in two core segments, with global geographic exposure.
    • No growth trajectory or historical revenue data is available for analysis.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Annual
    ANNUALFiled 2026-01-29
    FY 2026 · Full-year highlights

    Revenue CHF 7.47B, +0,8% YoY; Operating income −0,9% YoY.

    RevenueCHF 7.47B+0,8 % YoY
    Operating incomeCHF 1.38B−0,9 % YoY
    Net incomeCHF 1.07B−1,7 % YoY
    Free cash flowCHF 490.0M−7,4 % YoY
    EPS
    Operating cash flowCHF 1.51B−7,0 % YoY
    Financials
    Income statement
    RevenueCHF 7.47B
    Gross profitCHF 3.25B
    Operating incomeCHF 1.38B
    Net incomeCHF 1.07B
    Margins
    Gross margin43.5%
    Operating margin18.5%
    Net margin14.3%
    FCF margin6.6%
    Balance sheet
    Total assetsCHF 11.86B
    Total liabilitiesCHF 7.33B
    Total equityCHF 4.54B
    Cash & equivalents
    Long-term debtCHF 4.42B
    Cash flow
    Operating cash flowCHF 1.51B
    CapEx-CHF 305.0M
    Free cash flowCHF 490.0M
    SBC
    P&L flow · revenue → net income
    Revenue CHF 7.47BOperating costs CHF 6.09BTax CHF 310.0MNet income CHF 1.07B
    Highlights
    • Revenue CHF 7.47B, +0,8% YoY
    • Operating income −0,9% YoY
    • Net income −1,7% YoY
    • Free cash flow −7,4% YoY
    • Net margin 14.3%

    Valuation FY

    Market price
    $3 263,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    Net cash
    Current ratio
    Debt / equity
    ROA
    ROE
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    120,47
    Predicted surprise
    -0,00
    Beat probability
    45 %
    Analysts
    23
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-01 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate120,47
    Revenueno estimateno estimate7,5B CHF
    Operating incomeno estimateno estimate1,4B CHF
    Full-year consensus mean (period as reported by source) · consensus in CHF. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution23 analysts
    Strong buy4
    Buy5
    Hold11
    Sell2
    Strong sell1
    12-month price target$3 360,87 · Median $3 250,00
    Low $2 600,00High $4 500,00
    Operating income · consensus1,4B CHF
    EPS surprise
    −1,1 %
    reported vs consensus · miss
    Revenue surprise
    −0,9 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$2 600,00
    Mean$3 360,87
    Median$3 250,00
    High$4 500,00
    Spot$3 263,00
    +3.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskUnknown

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    Source documents
    • Givaudan SA Market data — financials · 2026-05-28
    • Givaudan SA Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Top holders

    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    — missing data

    Short positioning

    — missing data
    Index membership
    Swiss Market Index (SMI)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    GIVN.SCanonical
    — · USD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskUnknown

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    2026-06-20 00:43 UTCANALYSTAnalyst coverage initiated
    2026-01-29 05:08 UTCEARNINGSAnnual results — FY 2026 Revenue CHF 7.47B · Net CHF 1.07B
    2025-01-24 07:37 UTCEARNINGSAnnual results — FY 2025 Revenue CHF 7.41B · Net CHF 1.09B
    2024-07-22 13:00 UTCEARNINGSQuarterly results — Q2 2024
    2024-01-25 05:54 UTCEARNINGSAnnual results — FY 2024 Revenue CHF 6.92B · Net CHF 893.0M
    2023-01-25 08:18 UTCEARNINGSAnnual results — FY 2023 Revenue CHF 7.12B · Net CHF 856.0M
    2022-01-28 05:34 UTCEARNINGSAnnual results — FY 2022 Revenue CHF 6.68B · Net CHF 821.0M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage